On the contrary, in the ER-positive breast cancer cell line, MCF-7, EZH2 interacted with ER and activated the recruitment of the PRC2 complex on the NF-κB promoter where EZH2 tri-methylated H3K27 and repressed NF-κB transcription [61]. The gene discussed is NFKB1; the disease is breast cancer.